Financial results, events and calendar / Conference calls
  • Disease areas
  • Science & technology
  • Partnering & innovation
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Investors
  • News & media
  • Patient help
  • Healthcare professionals
  • Contact us

Full-year 2022 financial results were published 01 February 2023, 7:30 CET:

  • Company announcement
  • Investor presentation
  • Financial workbook (xlsx)


The conference call took place 01 February 2023, 13:00 CET

  • Conference call webcast 

London conference call webcast

Company announcement

Investor presentation

Financial workbook (xlsx)

Conference call webcast

 

London earnings conference call webcast

Company announcement

Investor presentation

Financial workbook (xlsx)

Conference call webcast

In connection with ADA 82nd Scientific Sessions Novo Nordisk A/S will host an investor event.

Listen to the webcast

Presentation (PDF)

London earnings conference call webcast

Company announcement

Investor presentation

Financial workbook (xlsx)

Conference call webcast

London earnings conference call webcast

Company announcement

Investor presentation

Financial workbook (xlsx)

Conference call webcast

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

Patient help Supplier help Product list Contact us Annual Report ESG reporting Novo Nordisk Foundation

Follow us

LinkedIn YouTube Facebook Twitter Instagram TikTok

Find your local office

Select location
© 2023 Novo Nordisk A/S Data Privacy Cookie policy Cookie settings

change